Konstantin Kazankov - Concepedia

Author

Konstantin Kazankov

Also Known As

Huang, K-W, K Kazankov, K. Kazankov, Kazankov, Konstantin, Konstantin Kazankov, Konstantin Kazankov (800268), Konstatin Kazankov

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Aarhus University Hospital The University of Sydney Westmead Hospital Westmead Institute Westmead Institute for Medical Research

About

Konstantin Kazankov is an author at Aarhus University Hospital specializing in metabolism, metabolic syndrome, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	3	3	225
2	Medicine	3	3	225
3	Diabetes	2	2	205
4	Public Health	1	1	37
5	Family Medicine	1	1	37

Konstantin Kazankov

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease Chiara Rosso, Konstantin Kazankov, Ramy Younes, Journal of Hepatology PathologyFatty Liver DiseaseInsulin SignalingObesityMetabolic Syndrome	2019	194
Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C Konstantin Kazankov, Francisco Barrera, Holger Jon Mφller, Hepatology	2014	174
Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging Konstantin Kazankov, Peter Holland‐Fischer, N.H. Andersen, Liver International	2011	124
The macrophage activation marker <scp>sCD</scp>163 is associated with morphological disease stages in patients with non‐alcoholic fatty liver disease Konstantin Kazankov, Francisco Barrera, Holger Jon Møller, Liver International	2016	109
Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients Mette Juul Nielsen, Konstantin Kazankov, Diana Julie Leeming, PLoS ONE	2015	65
The macrophage activation marker s<scp>CD</scp>163 is associated with changes in <scp>NAFLD</scp> and metabolic profile during lifestyle intervention in obese children Konstantin Kazankov, Holger Jon Møller, Aksel Lange, Pediatric Obesity	2014	60
Macrophage activation marker soluble <scp>CD</scp>163 and non‐alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery Konstantin Kazankov, Joan Tordjman, Holger Jon Møller, Journal of Gastroenterology and Hepatology	2015	59
Time‐dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct‐acting antiviral therapy of chronic hepatitis C Tea Lund Laursen, C. Siggaard, Konstantin Kazankov, Journal of Viral Hepatitis	2019	51
Single‐centre experience of the macrophage activation marker soluble (s)CD163 – associations with disease activity and treatment response in patients with autoimmune hepatitis Henning Grønbæk, M Kreutzfeldt, Konstantin Kazankov, Alimentary Pharmacology & Therapeutics	2016	45
Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury Mette Juul Nielsen, M.A. Karsdal, Konstantin Kazankov, Alimentary Pharmacology & Therapeutics	2016	37

Page 1